Study 2019-05 (HSR) Quality Indicators for the management of ovarian cancer

Ongoing study - In 2017 ovarian cancer was the 10th most frequent tumour in women in Belgium; 784 new cases were diagnosed that year and two-thirds of them were diagnosed in an advanced stage.

In 2016, KCE already published a guideline for the diagnosis, treatment and follow-up of ovarian cancer (KCE report 268). Based on this guideline, international audit reports and scientific publications, KCE will develop, in close collaboration with the Belgian Cancer Registry and a team of clinical experts, a set of indicators to evaluate the quality of care offered in Belgian hospitals to women with ovarian cancer. This approach has been successfully used to evaluate the quality of care offered to patients with breast cancer, testis cancer, oesophageal and stomach cancer, lung cancer and head and neck cancer. 

Previous analyses performed by the Belgian Cancer Registry demonstrated the huge dispersion of care for ovarian cancer patients. In 2004-2008, the management of these patients took place in 113 different hospitals, with a highly variable yearly volume. This study will investigate the current dispersion of care and the relationships between hospital volume, care processes and outcomes.

Published on: 
2020/02/18